✦ LIBER ✦
Sa1200 Presence and Concentration of OmpC As a Risk Factor for Developing Antibodies to Infliximab (ATI): Implications for Selecting Patients With Inflammatory Bowel Disease (IBD) for Combination Therapy
✍ Scribed by Lockton, Steven; Shah, Dhara; Princen, Fred; Hauenstein, Scott; Singh, Sharat; Levesque, Barrett G.; Sandborn, William; Feaga, Brian G.
- Book ID
- 122074265
- Publisher
- Elsevier Science
- Year
- 2014
- Tongue
- English
- Weight
- 378 KB
- Volume
- 146
- Category
- Article
- ISSN
- 0016-5085
No coin nor oath required. For personal study only.